Energy stocks dominated Q1 of 2025, while Tech and Consumer Discretionary suffered. Energy giants Chevron and Exxon had solid performances. Some Tech stocks shined.
FDA approves Sanofi's Qfitlia, the first antithrombin-lowering therapy for hemophilia A or B, reducing bleeding episodes with as few as six injections per year.
The Australian dollar remains range-bound near the 50-day EMA, with traders watching Chinese demand and global trade tensions for a potential breakout.
Workhorse Group shares are climbing in premarket trading after reporting a fiscal year 2024 sales drop of 49.5% to $6.616 million, missing estimates. The company posted a wider-than-expected EPS loss of $(51.69), but reduced operating losses and expenses. Workhorse aims to cut costs further while securing financial stability for its long-term strategy.
CEF shares trade on the exchanges and, unlike ETF shares, do not get any sponsor support. CEFs can trade at significant premiums or discounts to their net asset values.
Outdoor specialty retailer Sportsman's Warehouse (NASDAQ:SPWH) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
